Haemonetics
Haemonetics Employees
11 people indexed:
-
Anila Lingamneni
Executive Vice President, Chief Technology Officer
15yj10860yx@q08by52zxr0.qu2 Sign up to see emailvvbdj0zpx31@u5r5p556f45.rxj Sign up to see email -
pvw9zg@02j1kvbdz34.8w1 Sign up to see email
-
James C. D’Arecca
Executive Vice President, Chief Financial Officer
wk.l.p0bbfg@8zy8v208llp.bb3 Sign up to see email5k.b.2xzf1p@kugl2v24l5v.g8b Sign up to see email -
Jan Hartmann, M.D.
Senior Vice President, Chief Medical Officer
lu41pzg18.1.v@93u1xl00x0g.gg7 Sign up to see emailk703w5zw6.w.4@8v9z20w1qup.fwp Sign up to see email -
Josep Lluis Llorens
Executive Vice President, Global Manufacturing and Supply Chain
7yfxbp.1pdyk53@kx33ddw5zqv.dyp Sign up to see emailxz6x1b.w9w42bq@yz4yv45f618.k4b Sign up to see email -
Kerri DiPietro
Senior Vice President, Global Quality Assurance
vl65f7324@w4x84jf9q91.51w Sign up to see emailx7wwg9q4q@u1uu6yuy538.3q1 Sign up to see email -
Laurie Miller
Senior Vice President, Chief Human Resources Officer
wb37736@dyb3884jvkq.djy Sign up to see email497w863@pb9d195uk3j.b7w Sign up to see email -
Michelle L. Basil
Executive Vice President, General Counsel
65.k6z8q@9u44dz3gpkg.y8k Sign up to see emaily8.3426u@uqpqg0uqvwz.2fw Sign up to see email -
Rajeev Varma
Senior Vice President, Strategy and Corporate Development
4wp6z5@4y73ypx62d3.kk4 Sign up to see emailz2119b@xukbdgp77gu.p7d Sign up to see email -
87jqkj5@wqu1q9j7pk0.kf2 Sign up to see email
-
yk.uylb19@bxfp989371z.8fq Sign up to see email
Haemonetics Company Information
Haemonetics is a provider of innovative medical technology solutions aimed at improving the quality, effectiveness, and efficiency of care. The company offers technologies that increase plasma yield collections, enhance productivity, and ensure quality in plasma centers. It also delivers solutions that aid healthcare professionals in hospitals to enhance patient care and economic outcomes. Additionally, Haemonetics advances products and services for blood centers, focusing on blood safety and operational efficiency. The company has received FDA clearance for its TEG 6s Global Hemostasis - HN Cartridge, which marks a significant advancement in their product line. Recently, Haemonetics completed the acquisition of Attune Medical, expanding its portfolio and capabilities. The company is committed to corporate responsibility, with a framework that addresses environmental, social, and governance risks and opportunities. Haemonetics also provides a suite of web-based tools, online forms, and educational courses to support the use and understanding of its products and services, alongside offering technical support and detailed product information including safety data sheets and product certificates.